HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Insiders’ 2014 Forecast: Anti-Aging Hair Care To Drive Innovation

This article was originally published in The Rose Sheet

Executive Summary

Hair-care formulas that address thinning and aging hair are in high demand, say personal-care ingredient distributors and custom manufacturers in separate interviews. New anti-aging and skin-brightening ingredients, as well as multifunctional products, also are trending, they note.

You may also be interested in...



J&J Pits 5% Minoxidil Rogaine For Women Against ‘Cosmetic, Quick Fixes’

Firm’s McNeil-PPC subsidiary has patent exclusivity for Women’s Rogaine with the higher concentration of minoxidil through February 2017, tightening its grip on a market that cosmetics firms have struggled to penetrate effectively in the United States. According to a brand consultant and dermatologist, the new Rogaine offering actually helps regrow hair rather than merely “masking” the issue.

Hair Care Springboards Off Skin-Care Trends, Nail Color Slips In 2013

Anti-aging hair care and multifunctional alphabet creams for hair grew in 2013 where skin care left off, according to Kline & Company research. Meanwhile nail-care sales have plateaued after several years of double-digit gains, the market-intelligence firm says.

People In Brief: New Shiseido CEO; Ex-Heinz Exec To Lead Avon In Asia; More

Shiseido brings a new CEO on board to guide a “new phase” in the company’s development, the Japanese firm says. More people news.

Related Content

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

RS018848

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel